nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA14—telencephalon—malignant glioma	0.0142	0.0506	CbGeAlD
Methazolamide—CA7—midbrain—malignant glioma	0.0122	0.0436	CbGeAlD
Methazolamide—CA14—medulla oblongata—malignant glioma	0.0111	0.0398	CbGeAlD
Methazolamide—CA12—telencephalon—malignant glioma	0.011	0.0395	CbGeAlD
Methazolamide—CA14—midbrain—malignant glioma	0.0102	0.0363	CbGeAlD
Methazolamide—CA14—spinal cord—malignant glioma	0.00992	0.0354	CbGeAlD
Methazolamide—CA7—cerebellum—malignant glioma	0.00944	0.0337	CbGeAlD
Methazolamide—CA1—telencephalon—malignant glioma	0.00875	0.0313	CbGeAlD
Methazolamide—CA9—cerebellum—malignant glioma	0.00829	0.0296	CbGeAlD
Methazolamide—CA14—cerebellum—malignant glioma	0.00787	0.0281	CbGeAlD
Methazolamide—CA4—brainstem—malignant glioma	0.00771	0.0275	CbGeAlD
Methazolamide—CA7—brain—malignant glioma	0.00767	0.0274	CbGeAlD
Methazolamide—CA2—embryo—malignant glioma	0.00697	0.0249	CbGeAlD
Methazolamide—CA4—telencephalon—malignant glioma	0.00684	0.0244	CbGeAlD
Methazolamide—CA14—brain—malignant glioma	0.00639	0.0228	CbGeAlD
Methazolamide—CA2—brainstem—malignant glioma	0.00639	0.0228	CbGeAlD
Methazolamide—CA12—central nervous system—malignant glioma	0.00628	0.0224	CbGeAlD
Methazolamide—CA2—retina—malignant glioma	0.00616	0.022	CbGeAlD
Methazolamide—CA1—spinal cord—malignant glioma	0.00613	0.0219	CbGeAlD
Methazolamide—CA2—telencephalon—malignant glioma	0.00567	0.0203	CbGeAlD
Methazolamide—Digestion impaired—Temozolomide—malignant glioma	0.00567	0.0732	CcSEcCtD
Methazolamide—CA5B—central nervous system—malignant glioma	0.00563	0.0201	CbGeAlD
Methazolamide—SLC22A6—brain—malignant glioma	0.00556	0.0199	CbGeAlD
Methazolamide—CA4—medulla oblongata—malignant glioma	0.00537	0.0192	CbGeAlD
Methazolamide—CA12—brain—malignant glioma	0.00498	0.0178	CbGeAlD
Methazolamide—CA1—central nervous system—malignant glioma	0.00497	0.0178	CbGeAlD
Methazolamide—CA4—midbrain—malignant glioma	0.00491	0.0175	CbGeAlD
Methazolamide—CA4—spinal cord—malignant glioma	0.00479	0.0171	CbGeAlD
Methazolamide—CYP2E1—telencephalon—malignant glioma	0.00455	0.0162	CbGeAlD
Methazolamide—CA5B—brain—malignant glioma	0.00447	0.016	CbGeAlD
Methazolamide—CA2—medulla oblongata—malignant glioma	0.00446	0.0159	CbGeAlD
Methazolamide—CA2—midbrain—malignant glioma	0.00407	0.0145	CbGeAlD
Methazolamide—CYP2D6—brainstem—malignant glioma	0.00406	0.0145	CbGeAlD
Methazolamide—CA2—spinal cord—malignant glioma	0.00397	0.0142	CbGeAlD
Methazolamide—CA1—brain—malignant glioma	0.00395	0.0141	CbGeAlD
Methazolamide—CA4—central nervous system—malignant glioma	0.00389	0.0139	CbGeAlD
Methazolamide—CA4—cerebellum—malignant glioma	0.0038	0.0136	CbGeAlD
Methazolamide—CYP2D6—telencephalon—malignant glioma	0.0036	0.0129	CbGeAlD
Methazolamide—CYP2E1—medulla oblongata—malignant glioma	0.00357	0.0128	CbGeAlD
Methazolamide—Aplastic anaemia—Temozolomide—malignant glioma	0.00356	0.046	CcSEcCtD
Methazolamide—CA2—central nervous system—malignant glioma	0.00322	0.0115	CbGeAlD
Methazolamide—CYP2E1—spinal cord—malignant glioma	0.00319	0.0114	CbGeAlD
Methazolamide—CA2—cerebellum—malignant glioma	0.00315	0.0113	CbGeAlD
Methazolamide—CA4—brain—malignant glioma	0.00309	0.011	CbGeAlD
Methazolamide—Hepatic failure—Temozolomide—malignant glioma	0.00306	0.0395	CcSEcCtD
Methazolamide—CYP2E1—central nervous system—malignant glioma	0.00258	0.00923	CbGeAlD
Methazolamide—CA2—brain—malignant glioma	0.00256	0.00914	CbGeAlD
Methazolamide—CYP2E1—cerebellum—malignant glioma	0.00253	0.00902	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00248	0.032	CcSEcCtD
Methazolamide—Pancytopenia—Carmustine—malignant glioma	0.00234	0.0302	CcSEcCtD
Methazolamide—Pancytopenia—Temozolomide—malignant glioma	0.00226	0.0292	CcSEcCtD
Methazolamide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00217	0.028	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0021	0.0271	CcSEcCtD
Methazolamide—CYP3A4—central nervous system—malignant glioma	0.00208	0.00743	CbGeAlD
Methazolamide—CYP2E1—brain—malignant glioma	0.00205	0.00733	CbGeAlD
Methazolamide—CYP2D6—central nervous system—malignant glioma	0.00205	0.00731	CbGeAlD
Methazolamide—CYP2D6—cerebellum—malignant glioma	0.002	0.00715	CbGeAlD
Methazolamide—Erythema multiforme—Temozolomide—malignant glioma	0.0018	0.0232	CcSEcCtD
Methazolamide—Tinnitus—Temozolomide—malignant glioma	0.00177	0.0229	CcSEcCtD
Methazolamide—CYP2D6—brain—malignant glioma	0.00162	0.0058	CbGeAlD
Methazolamide—Dysgeusia—Temozolomide—malignant glioma	0.00162	0.021	CcSEcCtD
Methazolamide—Ill-defined disorder—Temozolomide—malignant glioma	0.00154	0.0199	CcSEcCtD
Methazolamide—Leukopenia—Carmustine—malignant glioma	0.00153	0.0198	CcSEcCtD
Methazolamide—Malaise—Temozolomide—malignant glioma	0.00149	0.0193	CcSEcCtD
Methazolamide—Vertigo—Temozolomide—malignant glioma	0.00149	0.0192	CcSEcCtD
Methazolamide—Convulsion—Carmustine—malignant glioma	0.00149	0.0192	CcSEcCtD
Methazolamide—Leukopenia—Temozolomide—malignant glioma	0.00148	0.0192	CcSEcCtD
Methazolamide—Convulsion—Temozolomide—malignant glioma	0.00144	0.0185	CcSEcCtD
Methazolamide—Confusional state—Carmustine—malignant glioma	0.00141	0.0182	CcSEcCtD
Methazolamide—Discomfort—Temozolomide—malignant glioma	0.00139	0.018	CcSEcCtD
Methazolamide—Confusional state—Temozolomide—malignant glioma	0.00136	0.0176	CcSEcCtD
Methazolamide—Anaphylactic shock—Temozolomide—malignant glioma	0.00135	0.0175	CcSEcCtD
Methazolamide—Anorexia—Carmustine—malignant glioma	0.00133	0.0172	CcSEcCtD
Methazolamide—Anorexia—Temozolomide—malignant glioma	0.00129	0.0166	CcSEcCtD
Methazolamide—Paraesthesia—Carmustine—malignant glioma	0.00126	0.0162	CcSEcCtD
Methazolamide—Somnolence—Carmustine—malignant glioma	0.00124	0.0161	CcSEcCtD
Methazolamide—Decreased appetite—Carmustine—malignant glioma	0.00122	0.0157	CcSEcCtD
Methazolamide—Paraesthesia—Temozolomide—malignant glioma	0.00121	0.0157	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00121	0.0156	CcSEcCtD
Methazolamide—Somnolence—Temozolomide—malignant glioma	0.0012	0.0155	CcSEcCtD
Methazolamide—Dyspepsia—Temozolomide—malignant glioma	0.00119	0.0154	CcSEcCtD
Methazolamide—Decreased appetite—Temozolomide—malignant glioma	0.00118	0.0152	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00117	0.0151	CcSEcCtD
Methazolamide—Fatigue—Temozolomide—malignant glioma	0.00117	0.0151	CcSEcCtD
Methazolamide—Feeling abnormal—Carmustine—malignant glioma	0.00115	0.0149	CcSEcCtD
Methazolamide—Feeling abnormal—Temozolomide—malignant glioma	0.00111	0.0144	CcSEcCtD
Methazolamide—Body temperature increased—Carmustine—malignant glioma	0.00111	0.0143	CcSEcCtD
Methazolamide—Urticaria—Temozolomide—malignant glioma	0.00107	0.0139	CcSEcCtD
Methazolamide—Body temperature increased—Temozolomide—malignant glioma	0.00107	0.0138	CcSEcCtD
Methazolamide—Asthenia—Carmustine—malignant glioma	0.001	0.013	CcSEcCtD
Methazolamide—Asthenia—Temozolomide—malignant glioma	0.00097	0.0125	CcSEcCtD
Methazolamide—Diarrhoea—Carmustine—malignant glioma	0.000957	0.0124	CcSEcCtD
Methazolamide—Diarrhoea—Temozolomide—malignant glioma	0.000925	0.0119	CcSEcCtD
Methazolamide—Vomiting—Carmustine—malignant glioma	0.00089	0.0115	CcSEcCtD
Methazolamide—Rash—Carmustine—malignant glioma	0.000882	0.0114	CcSEcCtD
Methazolamide—Dermatitis—Carmustine—malignant glioma	0.000881	0.0114	CcSEcCtD
Methazolamide—Headache—Carmustine—malignant glioma	0.000877	0.0113	CcSEcCtD
Methazolamide—Vomiting—Temozolomide—malignant glioma	0.00086	0.0111	CcSEcCtD
Methazolamide—Rash—Temozolomide—malignant glioma	0.000853	0.011	CcSEcCtD
Methazolamide—Dermatitis—Temozolomide—malignant glioma	0.000852	0.011	CcSEcCtD
Methazolamide—Headache—Temozolomide—malignant glioma	0.000847	0.0109	CcSEcCtD
Methazolamide—Nausea—Carmustine—malignant glioma	0.000831	0.0107	CcSEcCtD
Methazolamide—Nausea—Temozolomide—malignant glioma	0.000803	0.0104	CcSEcCtD
Methazolamide—CA14—Metabolism—PIK3CG—malignant glioma	0.00037	0.000575	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CAV1—malignant glioma	0.000369	0.000574	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CAV1—malignant glioma	0.000369	0.000574	CbGpPWpGaD
Methazolamide—CA9—Metabolism—SLC5A5—malignant glioma	0.000365	0.000568	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTP1—malignant glioma	0.000364	0.000567	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—COX8A—malignant glioma	0.000363	0.000564	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CG—malignant glioma	0.00036	0.000561	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CG—malignant glioma	0.00036	0.000561	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PPARG—malignant glioma	0.000357	0.000555	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CAT—malignant glioma	0.000354	0.000551	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTP1—malignant glioma	0.000349	0.000543	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000348	0.000542	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PPARG—malignant glioma	0.000348	0.000541	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PPARG—malignant glioma	0.000348	0.000541	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CAV1—malignant glioma	0.000342	0.000532	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CAT—malignant glioma	0.00034	0.000529	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000337	0.000524	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CG—malignant glioma	0.000336	0.000523	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CG—malignant glioma	0.000336	0.000523	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTP1—malignant glioma	0.000335	0.000521	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NCOR1—malignant glioma	0.000335	0.000521	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CAT—malignant glioma	0.000326	0.000507	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PIK3CD—malignant glioma	0.000325	0.000506	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PPARG—malignant glioma	0.000325	0.000505	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PPARG—malignant glioma	0.000325	0.000505	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NCOR1—malignant glioma	0.000321	0.000499	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000317	0.000494	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CD—malignant glioma	0.000317	0.000493	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CD—malignant glioma	0.000317	0.000493	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CG—malignant glioma	0.000312	0.000485	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ASMT—malignant glioma	0.000308	0.00048	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NCOR1—malignant glioma	0.000308	0.000479	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000307	0.000478	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PPARG—malignant glioma	0.000301	0.000468	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CD—malignant glioma	0.000296	0.00046	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CD—malignant glioma	0.000296	0.00046	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTP1—malignant glioma	0.000294	0.000458	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000293	0.000456	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—BCAN—malignant glioma	0.00029	0.000451	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.00029	0.000451	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CAT—malignant glioma	0.000286	0.000445	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000286	0.000444	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PIK3CB—malignant glioma	0.000283	0.000441	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PTGS2—malignant glioma	0.000281	0.000437	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—COX8A—malignant glioma	0.00028	0.000435	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CB—malignant glioma	0.000276	0.000429	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CB—malignant glioma	0.000276	0.000429	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CD—malignant glioma	0.000274	0.000426	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PTGS2—malignant glioma	0.000273	0.000426	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PTGS2—malignant glioma	0.000273	0.000426	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CAV1—malignant glioma	0.000273	0.000424	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NCOR1—malignant glioma	0.00027	0.000421	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CAV1—malignant glioma	0.000262	0.000407	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CB—malignant glioma	0.000258	0.000401	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CB—malignant glioma	0.000258	0.000401	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—COX8A—malignant glioma	0.000257	0.0004	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—malignant glioma	0.000255	0.000397	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—malignant glioma	0.000255	0.000397	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—COX8A—malignant glioma	0.000255	0.000397	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CAV1—malignant glioma	0.000251	0.00039	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00025	0.000389	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CG—malignant glioma	0.000248	0.000387	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PTEN—malignant glioma	0.000245	0.000381	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PPARG—malignant glioma	0.00024	0.000373	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CB—malignant glioma	0.000239	0.000371	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PTEN—malignant glioma	0.000239	0.000371	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PTEN—malignant glioma	0.000239	0.000371	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CG—malignant glioma	0.000238	0.000371	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ASMT—malignant glioma	0.000238	0.00037	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—malignant glioma	0.000237	0.000368	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—IDH2—malignant glioma	0.000234	0.000363	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000232	0.000362	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PPARG—malignant glioma	0.00023	0.000358	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CG—malignant glioma	0.000228	0.000355	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000228	0.000355	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BCAN—malignant glioma	0.000224	0.000348	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTEN—malignant glioma	0.000223	0.000346	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTEN—malignant glioma	0.000223	0.000346	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PPARG—malignant glioma	0.00022	0.000343	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CAV1—malignant glioma	0.00022	0.000343	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2B6—malignant glioma	0.00022	0.000342	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ASMT—malignant glioma	0.000219	0.00034	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CD—malignant glioma	0.000218	0.00034	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ASMT—malignant glioma	0.000217	0.000337	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000212	0.00033	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CD—malignant glioma	0.000209	0.000326	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTEN—malignant glioma	0.000206	0.000321	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BCAN—malignant glioma	0.000206	0.00032	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BCAN—malignant glioma	0.000204	0.000317	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000202	0.000314	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—IDH1—malignant glioma	0.000201	0.000313	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CG—malignant glioma	0.000201	0.000312	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CD—malignant glioma	0.000201	0.000312	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SPHK1—malignant glioma	0.000194	0.000302	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PPARG—malignant glioma	0.000194	0.000301	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2C18—malignant glioma	0.00019	0.000296	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CB—malignant glioma	0.00019	0.000296	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—malignant glioma	0.000189	0.000294	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CB—malignant glioma	0.000183	0.000284	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—malignant glioma	0.000181	0.000281	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—IDH2—malignant glioma	0.00018	0.00028	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CD—malignant glioma	0.000176	0.000275	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CB—malignant glioma	0.000175	0.000272	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—malignant glioma	0.000173	0.00027	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PIK3CA—malignant glioma	0.000173	0.000269	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00017	0.000264	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000169	0.000264	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CA—malignant glioma	0.000168	0.000262	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CA—malignant glioma	0.000168	0.000262	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—COX8A—malignant glioma	0.000168	0.000262	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—IDH2—malignant glioma	0.000166	0.000258	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTEN—malignant glioma	0.000165	0.000256	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—IDH2—malignant glioma	0.000164	0.000256	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTEN—malignant glioma	0.000158	0.000245	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CA—malignant glioma	0.000157	0.000244	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CA—malignant glioma	0.000157	0.000244	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000156	0.000243	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—IDH1—malignant glioma	0.000155	0.000241	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000155	0.000241	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000155	0.00024	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTT1—malignant glioma	0.000154	0.00024	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CB—malignant glioma	0.000154	0.000239	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—malignant glioma	0.000152	0.000237	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTEN—malignant glioma	0.000151	0.000235	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SPHK1—malignant glioma	0.00015	0.000233	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2C18—malignant glioma	0.000147	0.000229	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CA—malignant glioma	0.000146	0.000226	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS1—malignant glioma	0.000144	0.000225	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ASMT—malignant glioma	0.000143	0.000223	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—IDH1—malignant glioma	0.000143	0.000222	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—IDH1—malignant glioma	0.000141	0.00022	CbGpPWpGaD
Methazolamide—CA14—Metabolism—AKT1—malignant glioma	0.000141	0.000219	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000139	0.000216	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000138	0.000215	CbGpPWpGaD
Methazolamide—CA6—Metabolism—AKT1—malignant glioma	0.000137	0.000214	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—AKT1—malignant glioma	0.000137	0.000214	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000137	0.000213	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000135	0.00021	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BCAN—malignant glioma	0.000134	0.000209	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—BCHE—malignant glioma	0.000134	0.000209	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000134	0.000208	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTEN—malignant glioma	0.000133	0.000207	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC5A5—malignant glioma	0.000133	0.000206	CbGpPWpGaD
Methazolamide—CA7—Metabolism—AKT1—malignant glioma	0.000128	0.0002	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—AKT1—malignant glioma	0.000128	0.0002	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000126	0.000197	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000126	0.000196	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000122	0.00019	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—malignant glioma	0.000119	0.000185	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—malignant glioma	0.000119	0.000185	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—malignant glioma	0.000116	0.000181	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000115	0.000179	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS1—malignant glioma	0.000111	0.000173	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—malignant glioma	0.000111	0.000173	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000111	0.000173	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000111	0.000173	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000109	0.00017	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH2—malignant glioma	0.000108	0.000169	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000108	0.000169	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—malignant glioma	0.000107	0.000166	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—malignant glioma	0.000107	0.000166	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAT—malignant glioma	0.000104	0.000162	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BCHE—malignant glioma	0.000104	0.000161	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS1—malignant glioma	0.000102	0.000159	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC5A5—malignant glioma	0.000102	0.000159	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	0.000102	0.000159	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000102	0.000158	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000101	0.000157	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NCOR1—malignant glioma	9.81e-05	0.000153	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.67e-05	0.00015	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.58e-05	0.000149	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BCHE—malignant glioma	9.52e-05	0.000148	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—malignant glioma	9.48e-05	0.000148	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BCHE—malignant glioma	9.44e-05	0.000147	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC5A5—malignant glioma	9.4e-05	0.000146	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—malignant glioma	9.38e-05	0.000146	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC5A5—malignant glioma	9.32e-05	0.000145	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH1—malignant glioma	9.32e-05	0.000145	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—malignant glioma	9.09e-05	0.000141	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SPHK1—malignant glioma	9.02e-05	0.00014	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.84e-05	0.000137	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.82e-05	0.000137	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.74e-05	0.000136	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—malignant glioma	8.71e-05	0.000136	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.36e-05	0.00013	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—malignant glioma	8.24e-05	0.000128	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAT—malignant glioma	8.01e-05	0.000125	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAV1—malignant glioma	8e-05	0.000124	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—malignant glioma	7.66e-05	0.000119	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.62e-05	0.000119	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—malignant glioma	7.58e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOR1—malignant glioma	7.57e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—malignant glioma	7.51e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAT—malignant glioma	7.37e-05	0.000115	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAT—malignant glioma	7.31e-05	0.000114	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CG—malignant glioma	7.28e-05	0.000113	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—malignant glioma	7.15e-05	0.000111	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—malignant glioma	7.03e-05	0.000109	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOR1—malignant glioma	6.96e-05	0.000108	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOR1—malignant glioma	6.9e-05	0.000107	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS1—malignant glioma	6.7e-05	0.000104	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CD—malignant glioma	6.4e-05	9.96e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BCHE—malignant glioma	6.22e-05	9.69e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAV1—malignant glioma	6.17e-05	9.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.15e-05	9.57e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.89e-05	9.17e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAV1—malignant glioma	5.68e-05	8.83e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAV1—malignant glioma	5.63e-05	8.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.62e-05	8.75e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CB—malignant glioma	5.58e-05	8.69e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—malignant glioma	5.53e-05	8.61e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—malignant glioma	5.42e-05	8.44e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.37e-05	8.36e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.17e-05	8.04e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.12e-05	7.97e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—malignant glioma	4.99e-05	7.76e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—malignant glioma	4.95e-05	7.71e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—malignant glioma	4.95e-05	7.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.94e-05	7.69e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTEN—malignant glioma	4.82e-05	7.51e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAT—malignant glioma	4.82e-05	7.5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOR1—malignant glioma	4.55e-05	7.08e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.54e-05	7.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.51e-05	7.01e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.31e-05	6.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—malignant glioma	4.27e-05	6.64e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.96e-05	6.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.93e-05	6.11e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—malignant glioma	3.92e-05	6.11e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—malignant glioma	3.89e-05	6.05e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTEN—malignant glioma	3.72e-05	5.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAV1—malignant glioma	3.71e-05	5.77e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTEN—malignant glioma	3.42e-05	5.33e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.4e-05	5.29e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTEN—malignant glioma	3.39e-05	5.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.38e-05	5.26e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—malignant glioma	3.26e-05	5.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.97e-05	4.62e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—malignant glioma	2.78e-05	4.33e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.63e-05	4.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.59e-05	4.03e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—malignant glioma	2.57e-05	3.99e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.41e-05	3.76e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.39e-05	3.72e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTEN—malignant glioma	2.24e-05	3.48e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—malignant glioma	2.14e-05	3.34e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—malignant glioma	1.97e-05	3.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—malignant glioma	1.96e-05	3.04e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.58e-05	2.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—malignant glioma	1.29e-05	2.01e-05	CbGpPWpGaD
